Publication | Open Access
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
Alejandro Campos-Murguía,
Berenice M Román-Calleja,
Israel Vicente Toledo-Coronado,
José A González-Regueiro,
Alberto Adrián Solís-Ortega,
Deyanira Kúsulas-Delint,
Mariana Cruz-Contreras,
Nabila Cruz-Yedra,
Francisco Javier Cubero,
Yulia A. Nevzorova,
Digestive and Liver Disease